Legend Biotech LEGN Cash Flow Statement (2019-2026)

NASDAQ LEGN
$18.82 +0.20 (+1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Legend Biotech Quarterly Cash Flow Statement

Periods 29 quarters
Latest Jun 2026

Legend Biotech reported cash from operations of -$0.02B and free cash flow of -$0.01B for the quarter ended Jun 2026, down 58.3% year over year. This cash flow statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
289.92B293.20B308.70B309.78B-0.08B-0.14B-0.11B-0.20B-0.06B363.66B-0.06B-0.02B-0.13B402.81B-0.10B-0.00B-0.04B-0.03B-0.05B0.03B
Depreciation and DepletionDep. & Depletion
0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based CompensationStock Comp.
0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.01B0.01B0.02B0.02B0.02B0.01B0.02B0.02B0.02B0.01B0.02B0.02B
Gains from Sales and DivestituresGains Divest
0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Asset Writedowns and ImpairmentWritedown
0.00B0.00B0.00B-0.00B0.01B-0.00B-0.00B-0.00B0.00B0.00B-0.01B0.00B
Non-cash ItemsNon-Cash Items
-0.08B-0.13B-0.06B-0.10B-0.13B-0.11B-0.11B-0.08B-0.07B-0.10B-0.09B-0.01B-0.05B-0.05B-0.03B0.00B-0.02B0.01B-0.02B0.09B
Cash from OperationsCash from Ops.
-0.04B-0.20B-0.08B-0.00B-0.07B-0.05B-0.14B-0.10B-0.06B-0.10B0.02B-0.00B-0.08B-0.08B-0.10B-0.01B0.03B-0.01B-0.09B-0.02B
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Depreciation & Amortization (CF)Dep. & Amort.
0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in ReceivablesChange Receivables
0.01B-0.05B-0.00B0.05B0.00B-0.00B0.00B-0.02B0.02B-0.10B0.10B-0.01B0.01B-0.01B0.01B-0.03B0.03B-0.01B0.01B0.00B
Change in InventoryChange Inventory
0.00B-0.00B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.00B0.01B-0.00B0.00B-0.01B
Change in Account PayablesChange Payables
0.00B-0.00B0.00B0.00B0.03B0.04B-0.00B-0.01B-0.00B-0.03B0.02B-0.00B-0.01B0.01B0.02B0.02B0.02B-0.02B-0.01B0.00B
Change in Accured ExpensesChange Accured Exp.
0.04B0.08B-0.02B0.08B0.06B0.00B-0.04B0.02B-0.01B0.03B0.01B0.04B0.00B-0.00B-0.04B0.02B0.01B0.05B-0.07B-0.01B
Change in TaxesChange Taxes
0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B
Other Working Capital ChangesOther WC Changes
-0.00B-0.00B-0.00B-0.03B-0.03B0.01B0.01B-0.02B0.00B0.01B-0.02B-0.01B0.03B-0.00B0.00B0.00B-0.00B0.01B-0.00B0.00B
Investing Activities
Capital ExpendituresCapex
-0.01B-0.04B-0.01B0.00B-0.00B-0.02B-0.00B-0.01B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00B-0.00B0.00B-0.00B-0.00B
Change in IntangiblesChange Intangibless
-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B
Cash from Investing ActivitiesCash from Investing
-0.11B-0.19B-0.23B0.00B0.13B0.02B0.02B-0.12B-0.21B0.41B-0.40B-0.70B0.33B-0.09B0.26B-0.17B-0.02B0.64B-0.17B-0.12B
Financing Activities
Other financing activitiesOther financing
0.22B0.17B0.29B-0.16B0.19B0.79B0.05B0.34B2.34B1.28B0.50B0.69B-0.43B0.84B0.37B0.33B0.01B0.90B0.18B0.11B
Cash from Financing ActivitiesCash from Financing
0.00B0.32B0.00B0.00B0.38B-0.00B-0.00B0.79B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.17B
Change in Capital Stock
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Additional items
Exchange Rate EffectFX Effect
-0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B-0.00B
Change in Cash
-0.15B0.35B-0.31B0.00B0.43B-0.03B-0.12B0.57B-0.27B0.31B-0.38B-0.70B0.26B-0.17B0.15B-0.18B0.01B0.62B-0.26B0.03B
Beginning Cash Balance
0.49B0.34B0.69B0.81B0.79B0.96B0.46B0.28B
Free Cash FlowFCF
-0.03B-0.16B-0.07B-0.00B-0.07B-0.03B-0.13B-0.09B-0.06B-0.09B0.02B0.00B-0.07B-0.08B-0.10B-0.00B0.03B0.00B-0.08B-0.01B
Net Cash FlowNCF
-0.15B-0.07B-0.31B0.00B0.43B-0.03B-0.12B0.57B-0.27B0.31B-0.38B-0.70B0.26B-0.17B0.15B-0.18B0.01B0.63B-0.25B0.03B

Legend Biotech Cash Flow Statement API

Pull Legend Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LEGN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY